[Promoting effect on NK cells induced by myeloid-derived suppressor cells in acute fulminate hepatitis of mice].

Zhejiang Da Xue Xue Bao Yi Xue Ban

Institute of Immunology, College of Medicine, Zhejiang University, Hangzhou 310058, China.

Published: July 2010

Objective: To investigate the interaction between myeloid-derived suppressor cells (MDSCs) and nature killer cells during acute fulminate hepatitis.

Methods: Acute fulminate hepatitis were induced by i.p. co-injection of LPS and D-GalN in mice, and the ratio of MDSCs,NK cells and the activation of NK cells in different tissues were analyzed by FACS at 0 h,1.5 h,3 h and 6 h.

Results: The percentage of MDSCs and NKG2D+NK cells in different tissues increased as acute fulminate hepatitis progressed, with the increased NK cells in liver tissue. The mean fluorescence intensity of NKG2D on NK cells in different tissues were also enhanced.

Conclusion: MDSCs induce the proliferation and activation of NK cells in mice with acute fulminate hepatitis.

Download full-text PDF

Source
http://dx.doi.org/10.3785/j.issn.1008-9292.2010.04.004DOI Listing

Publication Analysis

Top Keywords

acute fulminate
20
fulminate hepatitis
16
cells tissues
12
cells
9
myeloid-derived suppressor
8
suppressor cells
8
cells acute
8
activation cells
8
acute
5
fulminate
5

Similar Publications

Immunotherapy-induced hepatitis is a well-known and relatively common side effect of immune checkpoint inhibitors. It is usually mild to moderate and responds well to corticosteroids with a full recovery. However, in rare cases, severe liver injury may develop, leading to fulminant liver failure.

View Article and Find Full Text PDF

Acute liver failure (ALF) is a fulminant clinical syndrome that usually leads to multiple organ failure and high mortality. Macrophages play a crucial role in the initiation, development, and recovery of ALF. Targeting macrophages through immunotherapy holds significant promise as a therapeutic strategy.

View Article and Find Full Text PDF

Background Cholangitis, or bile duct infection, can present in two primary forms, namely, acute ascending cholangitis (the milder form) and acute fulminant cholangitis (the more severe variety). In all types of cholangitis, bile duct obstruction occurs, with choledocholithiasis (the presence of gallstones in the bile duct) being the leading cause of this blockage. is the most commonly isolated pathogen in these infections.

View Article and Find Full Text PDF

Background: Fulminant virus-associated encephalopathy (VAE) is a rare complication of viral infection that presents as acute brain dysfunction and requires respiratory support and/or vasoactive agents. However, the mechanism of VAE is undetermined. The mortality rate is high since there is no specific treatment for fulminant VAE.

View Article and Find Full Text PDF

Coagulopathy in acute liver failure.

Best Pract Res Clin Gastroenterol

December 2024

Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address:

Acute liver failure (ALF) is a rare but rapidly progressing syndrome, marked by severe liver dysfunction and altered mental status. While definitions of ALF vary across different guidelines, with timelines ranging from 4 to 26 weeks between jaundice onset and encephalopathy, the key defining features remain encephalopathy and coagulopathy. Elevated coagulation markers, particularly prothrombin time and international normalized ratio, have traditionally been associated with bleeding risks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!